American Well (AMWL)
(Delayed Data from NYSE)
$0.54 USD
-0.01 (-1.76%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $0.54 0.00 (-0.48%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AMWL 0.54 -0.01(-1.76%)
Will AMWL be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for AMWL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMWL
American Well Corporation (AMWL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates
AMWL: What are Zacks experts saying now?
Zacks Private Portfolio Services
American Well Corporation (AMWL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
American Well Corporation (AMWL) Reports Q2 Earnings: What Key Metrics Have to Say
American Well Corporation (AMWL) Reports Q2 Loss, Lags Revenue Estimates
Other News for AMWL
Amwell® to Report First Quarter 2024 Operating Results May 1
House eyes extension of pandemic-era Medicare telehealth benefits, Axios reports
Amwell Receives Continued Listing Standard Notice From NYSE
American Well Faces NYSE Delisting Risk, Considers Reverse Split
Amwell receives continued listing standard notice from NYSE